Copper Peptide Upregulation refers to the targeted biological strategy of increasing the expression or activity of copper-binding peptides, such as GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper). These small signaling molecules play a pivotal role in numerous physiological processes, particularly wound healing, tissue remodeling, and anti-inflammatory responses. This upregulation is pursued to enhance regenerative capacity and skin health.
Origin
The concept stems from the discovery and subsequent research into copper-dependent enzymes and peptides, with GHK-Cu being identified by Dr. Loren Pickart in the early 1970s. Its application in clinical and cosmetic contexts is based on its potent signaling properties in tissue repair. The term highlights the therapeutic use of these metallopeptides.
Mechanism
Copper peptides function by delivering copper to cells and acting as molecular signals that promote the synthesis of collagen, elastin, and glycosaminoglycans by fibroblasts. Upregulation of these signals stimulates the expression of antioxidant enzymes and suppresses inflammatory pathways, leading to improved skin structure and accelerated healing kinetics. This mechanism supports dermal integrity and resilience.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.